Albany Molecular Research Inc (AMRI.O)

AMRI.O

About

Albany Molecular Research, Inc. (AMRI) is a contract research and manufacturing company. The Company provides customers with fully integrated drug discovery, development and manufacturing services. The Company operates in two segments: Large Scale Manufacturing (LSM) and Discovery, Drug Development and Small Scale Manufacturing... (more)

Buy/Sell

No analyst recommendations are available for AMRI.O.

» Analyst Consensus

Overall

Beta:	1.30
Market Cap (Mil.):	$342.77
Shares Outstanding (Mil.):	31.42
Dividend:	--
Yield (%):	--

Financials

	AMRI.O	Industry	Sector
P/E (TTM):	52.36	53.09	35.13
EPS (TTM):	0.21	--	--
ROI:	2.86	0.99	18.83
ROE:	3.12	1.98	19.68

Latest News about AMRI.O

» More AMRI.O News

Competitors

	Price	Change
Johnson & Johnson (JNJ.N)	$88.46	-0.13
Abbott Laboratories (ABT.N)	$37.72	0.00
Bristol Myers Squibb Co. (BMY.N)	$46.40	+2.34
Bristol Myers Squibb Co. (BMY_p.N)	$567.60	0.00
Amgen, Inc. (AMGN.OQ)	$104.53	+0.29
Merck KGaA (MRCG.DE)	€123.50	+4.10
Gilead Sciences, Inc. (GILD.OQ)	$55.93	-0.48
Biogen Idec Inc. (BIIB.OQ)	$233.07	+1.74
Celgene Corporation (CELG.OQ)	$123.44	-0.06
Forest Laboratories, Inc. (FRX.N)	$37.51	-0.41

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Thomson Reuters Stock Report - ALBANY MOLECULAR RESEARCH INCORPORATED (AMRI-O) Provider: Thomson Reuters Stock Report	$25.00 Buy
Albany Molecular Research, Inc. (AMRI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Provider: GlobalData	$250.00 Buy
Market Edge Equity Research Report Provider: Market Edge	$10.00 Buy
ALBANY MOLECULAR RESEARCH (AMRI) 12-months forecast Provider: Pechala's Reports	$15.00 Buy
Albany Molecular Research Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.